NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/01/2023
Back to search
Official data from USPTO
BEAM THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BEAM THERAPEUTICS
ST13
US500000088460824Class
42
Filing
88460824
Registration
7127500
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
08/01/2023
Trademark type
Word
Nice classes
42
Filing date
06/05/2019
Registration date
08/01/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/01/2023
Last transaction
08/01/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/30/2021
First use in commerce
06/30/2021
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
ANKRAH, NAAKWAMA
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Beam Therapeutics Inc.
Representatives
John V. Hobgood, Esquire Wilmer Cutler Pickering Hale and Dorr LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and medical research in the fields of base editingbase modificationbase repairnucleobase editingnucleobase modificationnucleobase repairnucleic acid editinggene editinggene modificationgene modulationgene reprogramminggenome editinggenome modificationcellular modificationtissue modificationorgan modification; providing scientific and medical research informationbioinformatic algorithms and models in the fields of base editingbase modificationbase repairnucleobase editingnucleobase modificationnucleobase repairnucleic acid editinggene editinggene modificationgene modulationgene reprogramminggenome editinggenome modificationcellular modificationtissue modificationorgan modification; scientific study and research in the fields of base editingbase modificationbase repairnucleobase editingnucleobase modificationnucleobase repairnucleic acid editinggene editinggene modificationgene modulationgene reprogramminggenome editinggenome modificationcellular modificationtissue modificationorgan modification to develop human pharmaceutical and biological preparations
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/01/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/30/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/29/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/19/2023
IUAF
USE AMENDMENT FILED
05/16/2023
EISU
TEAS STATEMENT OF USE RECEIVED
05/16/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/09/2022
EX5G
SOU EXTENSION 5 GRANTED
11/08/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/08/2022
EXT5
SOU EXTENSION 5 FILED
11/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/01/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/20/2022
EX4G
SOU EXTENSION 4 GRANTED
05/18/2022
EXT4
SOU EXTENSION 4 FILED
05/18/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/18/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/26/2021
EX3G
SOU EXTENSION 3 GRANTED
11/24/2021
EXT3
SOU EXTENSION 3 FILED
11/24/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/24/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/27/2021
EX2G
SOU EXTENSION 2 GRANTED
05/25/2021
EXT2
SOU EXTENSION 2 FILED
05/25/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/25/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/26/2020
EX1G
SOU EXTENSION 1 GRANTED
11/24/2020
EXT1
SOU EXTENSION 1 FILED
11/24/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/24/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/26/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2020
PUBO
PUBLISHED FOR OPPOSITION
03/31/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/25/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
02/25/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/25/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
02/25/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/25/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/28/2019
GNRT
NON-FINAL ACTION E-MAILED
08/28/2019
CNRT
NON-FINAL ACTION WRITTEN
08/28/2019
DOCK
ASSIGNED TO EXAMINER
08/27/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/21/2019
NWAP
NEW APPLICATION ENTERED
06/08/2019
Continuous trademark protection
Get notified about every new filing that threatens BEAM THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.